{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:46:34Z","timestamp":1759826794477,"version":"3.40.5"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Introduction<\/jats:title><jats:p>The demographics of those developing severe coronavirus disease (COVID-19) outcomes are shifting to younger patients. In an observational study utilizing electronic health records from a Massachusetts group medical practice, we identified 5025 patients with confirmed COVID-19 from March 1 to December 18, 2020. Of these, 3870 were under 65 years of age. We investigated the hypothesis that pre-infection metabolic or immunologic dysregulation including polycystic ovary syndrome (PCOS) increased risk of serious COVID-19 outcomes in patients under 65 years of age.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Materials and methods<\/jats:title><jats:p>We compared those with COVID-19 related hospitalization or mortality to all other COVID-19 patients, using a case control approach. Using logistic regression and propensity score modeling, we evaluated risk of developing severe COVID-19 outcomes (hospitalization or death) in those with<jats:italic>pre-infection<\/jats:italic>comorbidities, metabolic risk factors, or PCOS.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>Overall, propensity score matched analyses demonstrated<jats:italic>pre-infection<\/jats:italic>elevated liver enzymes alanine aminotransferase (ALT) &gt;40, aspartate aminotransferase (AST) &gt;40 and blood glucose \u2265215 mg\/dL were associated with more severe COVID-19 outcomes, OR = 1.74 (95% CI 1.31, 2.31); OR = 1.98 (95% CI 1.52, 2.57), and OR = 1.55 (95% CI 1.08, 2.23) respectively. Elevated hemoglobin A1C or blood glucose levels were even stronger risk factors for severe COVID-19 outcomes among those aged &lt; 65, OR = 2.31 (95% CI 1.14, 4.66) and OR = 2.42 (95% CI 1.29, 4.56), respectively. In logistic regression models, women aged &lt; 65 with PCOS demonstrated more than a four-fold increased risk of severe COVID-19, OR 4.64 (95% CI 1.98, 10.88).<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>Increased risk of severe COVID-19 outcomes in those &lt; age 65 with<jats:italic>pre-infection<\/jats:italic>indicators of metabolic dysfunction heightens the importance of monitoring pre-infection indicators in younger patients for prevention and early treatment. The PCOS finding deserves further investigation. Meanwhile women who suffer from PCOS should be carefully evaluated and prioritized for earlier COVID-19 treatment and vaccination.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0287430","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T18:11:10Z","timestamp":1686852670000},"page":"e0287430","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting patients for early COVID-19 therapy; Pre-infection metabolic dysfunction, polycystic ovary syndrome and risk of severe disease in patients under 65: A Massachusetts community-based observational study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0182-598X","authenticated-orcid":true,"given":"Susan R.","family":"Sama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Z.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-5421","authenticated-orcid":true,"given":"Lawrence","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Rosiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devi","family":"Sundaresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kriebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"journal-title":"COVID-19 Weekly Cases and Deaths per 100,000 Population by Age, Race\/Ethnicity, and Sex","year":"2021","author":"Centers for Disease Control and Prevention","key":"pone.0287430.ref001"},{"key":"pone.0287430.ref002","article-title":"REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021.","author":"S Riley","year":"2021","journal-title":"medRxiv."},{"issue":"3","key":"pone.0287430.ref003","doi-asserted-by":"crossref","first-page":"102439","DOI":"10.1016\/j.dsx.2022.102439","article-title":"Glucose dysregulation and its association with COVID-19 mortality and hospital length of stay","volume":"16","author":"S Mirabella","year":"2022","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"pone.0287430.ref004","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.4239\/wjd.v12.i10.1674","article-title":"Interactions between diabetes and COVID-19: A narrative review.","volume":"12","author":"S Sabri","year":"2021","journal-title":"World J Diabetes."},{"key":"pone.0287430.ref005","doi-asserted-by":"crossref","first-page":"726696","DOI":"10.3389\/fendo.2021.726696","article-title":"Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones.","volume":"12","author":"F Tramontana","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"pone.0287430.ref006","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12944-021-01564-z","article-title":"Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.","volume":"20","author":"Y Xu","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"1","key":"pone.0287430.ref007","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12916-021-01944-3","article-title":"Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study.","volume":"19","author":"SL Au Yeung","year":"2021","journal-title":"BMC Med."},{"issue":"3","key":"pone.0287430.ref008","doi-asserted-by":"crossref","first-page":"101254","DOI":"10.1016\/j.diabet.2021.101254","article-title":"Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study","volume":"47","author":"M Mamtani","year":"2021","journal-title":"Diabetes Metab"},{"issue":"3","key":"pone.0287430.ref009","doi-asserted-by":"crossref","DOI":"10.3390\/diseases9030050","article-title":"Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis.","volume":"9","author":"DA McGrowder","year":"2021","journal-title":"Diseases."},{"issue":"4","key":"pone.0287430.ref010","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2337\/dc20-1448","article-title":"Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring","volume":"44","author":"Y Shen","year":"2021","journal-title":"Diabetes Care"},{"key":"pone.0287430.ref011","doi-asserted-by":"crossref","first-page":"8812304","DOI":"10.1155\/2021\/8812304","article-title":"Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.","volume":"2021","author":"W Zhang","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"4","key":"pone.0287430.ref012","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.21786\/bbrc\/13.4\/12","article-title":"The Common Pathological Factors Between Polycystic Ovary Syndrome and COVID-19 Infection: A Review","volume":"13","author":"A. Alahmadi","year":"2020","journal-title":"Bioscience Biotechnology Research Communications"},{"issue":"2","key":"pone.0287430.ref013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11154-022-09715-y","article-title":"Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship.","volume":"23","author":"SF de Medeiros","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"pone.0287430.ref014","first-page":"221","article-title":"Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection?","volume":"18","author":"B. Dilbaz","year":"2021","journal-title":"Turk J Obstet Gynecol"},{"issue":"12","key":"pone.0287430.ref015","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.12998\/wjcc.v9.i12.2711","article-title":"Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19.","volume":"9","author":"I Ilias","year":"2021","journal-title":"World J Clin Cases"},{"issue":"1","key":"pone.0287430.ref016","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12916-020-01697-5","article-title":"Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic.","volume":"18","author":"I Kyrou","year":"2020","journal-title":"BMC Med."},{"key":"pone.0287430.ref017","doi-asserted-by":"crossref","first-page":"105770","DOI":"10.1016\/j.jsbmb.2020.105770","article-title":"Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?","volume":"205","author":"G Morgante","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"pone.0287430.ref018","first-page":"e3398","article-title":"Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes","author":"E Merzon","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"pone.0287430.ref019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"J Yang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"10229","key":"pone.0287430.ref020","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"pone.0287430.ref021","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1463-1326.2009.01160.x","article-title":"Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature","volume":"12","author":"L Nalysnyk","year":"2010","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"pone.0287430.ref022","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical Features of COVID-19-Related Liver Functional Abnormality","volume":"18","author":"Z Fan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0287430.ref023","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/liv.14465","article-title":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis","volume":"40","author":"A Mantovani","year":"2020","journal-title":"Liver Int"},{"issue":"2","key":"pone.0287430.ref024","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12072-021-10141-6","article-title":"Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil.","volume":"15","author":"FM Pozzobon","year":"2021","journal-title":"Hepatol Int."},{"key":"pone.0287430.ref025","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2147\/IDR.S321915","article-title":"Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients.","volume":"14","author":"J Qu","year":"2021","journal-title":"Infect Drug Resist."},{"issue":"3","key":"pone.0287430.ref026","doi-asserted-by":"crossref","first-page":"100258","DOI":"10.1016\/j.jhepr.2021.100258","article-title":"Abnormal liver tests in patients with SARS-CoV-2 or influenza\u2014prognostic similarities and temporal disparities.","volume":"3","author":"N Shafran","year":"2021","journal-title":"JHEP Rep."},{"issue":"1","key":"pone.0287430.ref027","first-page":"28","article-title":"Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.","volume":"7","author":"Q Wang","year":"2020","journal-title":"Mil Med Res."},{"issue":"2","key":"pone.0287430.ref028","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"R Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0287430.ref029","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"WA March","year":"2010","journal-title":"Hum Reprod"},{"issue":"4","key":"pone.0287430.ref030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/humupd\/dmab004","article-title":"Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome","volume":"27","author":"SF de Medeiros","year":"2021","journal-title":"Hum Reprod Update"},{"issue":"4","key":"pone.0287430.ref031","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/ijmr.IJMR_1937_17","article-title":"Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India","volume":"150","author":"MA Ganie","year":"2019","journal-title":"Indian J Med Res"},{"issue":"1","key":"pone.0287430.ref032","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.","volume":"17","author":"D Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol."},{"issue":"8","key":"pone.0287430.ref033","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"RS Legro","year":"2001","journal-title":"Am J Med"},{"issue":"2","key":"pone.0287430.ref034","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000189809","article-title":"Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome","volume":"18","author":"X Ruan","year":"2009","journal-title":"Med Princ Pract"},{"issue":"1","key":"pone.0287430.ref035","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection","volume":"7","author":"Q Wu","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"pone.0287430.ref036","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1358\/dot.2009.45.10.1429463","article-title":"Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.","volume":"45","author":"V De Leo","year":"2009","journal-title":"Drugs Today (Barc)."},{"key":"pone.0287430.ref037","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fendo.2019.00699","article-title":"Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs.","volume":"10","author":"MA Ganie","year":"2019","journal-title":"Non-vegetarian Diet. Front Endocrinol (Lausanne)."},{"issue":"2","key":"pone.0287430.ref038","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/jhrs.jhrs_79_21","article-title":"Polycystic Ovary Syndrome and COVID-19: An Emerging Risk Factor","volume":"14","author":"SR Joshi","year":"2021","journal-title":"J Hum Reprod Sci"},{"issue":"5","key":"pone.0287430.ref039","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/EJE-20-1163","article-title":"Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study","volume":"184","author":"A Subramanian","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"pone.0287430.ref040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"R Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"pone.0287430.ref041","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser B. Revised","year":"2004","journal-title":"Fertil Steril"},{"issue":"4","key":"pone.0287430.ref042","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.","volume":"7","author":"MO Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"pone.0287430.ref043","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.metop.2020.100052","article-title":"Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?","volume":"7","author":"ASM Moin","year":"2020","journal-title":"Metabol Open."},{"key":"pone.0287430.ref044","first-page":"1","article-title":"Hypertension, medications and risk of severe COVID-19: A Massachusetts community-based observational study.","volume":"00","author":"GR Bauer AZ","year":"2020","journal-title":"J Clin Hypertens."},{"key":"pone.0287430.ref045","unstructured":"CDC. ICD-10-CM Official Coding and Reporting Guidelines April 1, 2020 through September 30, 2020 Centers for Disease Control and Prevention; 2020 [cited 2021 9\/3\/21]. Available from: https:\/\/www.cdc.gov\/nchs\/data\/icd\/COVID-19-guidelines-final.pdf."},{"issue":"4","key":"pone.0287430.ref046","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/oxfordjournals.aje.a010011","article-title":"Invited commentary: propensity scores","volume":"150","author":"MM Joffe","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0287430.ref047","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score.","volume":"39","author":"PR Rosenbaum","year":"1985","journal-title":"Am Stat."},{"key":"pone.0287430.ref048","article-title":"Characterization and clinical course of 1000 Patients with COVID-19 in New York: retrospective case series.","author":"MG Argenziano","year":"2020","journal-title":"medRxiv"},{"issue":"8","key":"pone.0287430.ref049","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s00125-020-05164-x","article-title":"Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature","volume":"63","author":"P Katulanda","year":"2020","journal-title":"Diabetologia"},{"issue":"2","key":"pone.0287430.ref050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"M Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"1","key":"pone.0287430.ref051","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.202003-0821OC","article-title":"COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids","volume":"202","author":"MC Peters","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"pone.0287430.ref052","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.eprac.2021.05.011","article-title":"Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review.","volume":"27","author":"MM Kristan","year":"2021","journal-title":"Endocr Pract"},{"issue":"2","key":"pone.0287430.ref053","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/03630269.2021.1926278","article-title":"Association between Hb A1c and Severity of COVID-19 Patients","volume":"45","author":"G Unluguzel Ustun","year":"2021","journal-title":"Hemoglobin"},{"issue":"4","key":"pone.0287430.ref054","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1932296820924469","article-title":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.","volume":"14","author":"B Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"pone.0287430.ref055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jmv.26227","article-title":"Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19","volume":"93","author":"SM Smith","year":"2021","journal-title":"J Med Virol"},{"issue":"2","key":"pone.0287430.ref056","first-page":"125","article-title":"Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis.","volume":"113","author":"J Ampuero","year":"2021","journal-title":"Rev Esp Enferm Dig."},{"issue":"24","key":"pone.0287430.ref057","first-page":"13072","article-title":"Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.","volume":"24","author":"F Del Zompo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"1","key":"pone.0287430.ref058","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1038\/s41598-021-89340-y","article-title":"Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity.","volume":"11","author":"J Wagner","year":"2021","journal-title":"Sci Rep."},{"issue":"1","key":"pone.0287430.ref059","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MEG.0000000000001742","article-title":"Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.","volume":"33","author":"G Lippi","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"pone.0287430.ref060","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.31446","article-title":"Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study.","volume":"73","author":"Y Fu","year":"2021","journal-title":"Hepatology."},{"issue":"14","key":"pone.0287430.ref061","first-page":"7855","article-title":"Severe COVID-19 patients with liver injury: a seven-case series","volume":"24","author":"X Li","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"pone.0287430.ref062","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s43032-020-00369-2","article-title":"Vitamin D and Polycystic Ovary Syndrome: a Narrative Review.","volume":"28","author":"Y Mu","year":"2021","journal-title":"Reprod Sci."},{"issue":"56","key":"pone.0287430.ref063","doi-asserted-by":"crossref","first-page":"96351","DOI":"10.18632\/oncotarget.19180","article-title":"The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis.","volume":"8","author":"T Ding","year":"2017","journal-title":"Oncotarget."},{"key":"pone.0287430.ref064","first-page":"1","article-title":"Serum vitamin D levels in relation to type-2 diabetes and prediabetes in adults: a systematic review and dose-response meta-analysis of epidemiologic studies","volume":"2021","author":"S Mohammadi","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"pone.0287430.ref065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations.","volume":"51","author":"PC Austin","year":"2009","journal-title":"Biom J"},{"issue":"3","key":"pone.0287430.ref066","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3102\/1076998612441947","article-title":"Improving Generalizations From Experiments Using Propensity Score Subclassification: Assumptions, Properties, and Contexts","volume":"38","author":"E. Tipton","year":"2013","journal-title":"Journal of Educational and Behavioral Statistics"},{"journal-title":"We Have the Technology to Stop Superspreading Without Masks New York: The New York Times","year":"2022","author":"NE Milton DK","key":"pone.0287430.ref067"},{"key":"pone.0287430.ref068","article-title":"Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis.","author":"J Deng","year":"2022","journal-title":"Infection"},{"issue":"1","key":"pone.0287430.ref069","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19a meta-analysis.","volume":"54","author":"W Wen","year":"2022","journal-title":"Ann Med."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T10:32:10Z","timestamp":1729593130000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287430"}},"subtitle":[],"editor":[{"given":"Samiullah","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":69,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0287430","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}